Australia covid-19 infection patient Australia

Australia’s TGA approves remdesivir as first Covid-19 treatment

Reading now: 927
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Therapeutic Goods Administration (TGA) of Australia has awarded provisional approval for the use of Gilead Sciences’ remdesivir (Veklury) to treat Covid-19 patients, marking the first authorisation of treatment for this disease in the country.

The approval enables the use of the drug in adults and adolescents hospitalised with severe Covid-19 symptoms. TGA noted that, so far, remdesivir demonstrated the most promise as a treatment option to decrease hospitalisation time for people with coronavirus infections.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA